Cart
sales@molnova.com
(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
CAS No. 146504-07-6
(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine( —— )
Catalog No. M18038 CAS No. 146504-07-6
Cyclohexanediamine has a potential of anticancer activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 27 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(1R,2R)-Trans-N-Boc-1,2-Cyclohexanediamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclohexanediamine has a potential of anticancer activity.
-
DescriptionCyclohexanediamine has a potential of anticancer activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number146504-07-6
-
Formula Weight214.31
-
Molecular FormulaC11H22N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)(C)OC(=O)N[C@@H]1CCCC[C@H]1N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Erlotinib mesylate
Erlotinib (CP-358774;OSI-774;NSC 718781) is a potent, selective inhibitor of EGFR with IC50 of 2 nM.
-
(E)-AG 556
AG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.
-
Befotertinib
Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cell lung cancer.
